NeurogesX’s Qutenza Receives Positive EU Committee Recommendation

NeurogesX, Inc. … announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive opinion recommending approval of Qutenza for the treatment of peripheral neuropathic pain in non-diabetic adults either alone or in combination with other medicinal products for pain.
News Blaze